APIs
A Changing Paradigm for Pharmaceutical Chemical Outsourcing
Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
Industry experts share perspectives on the changing fundamentals and business models for outsourcing pharmaceutical chemical development and manufacturing.

Biologics
A Mixed Review for Biotechnology Financing
Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
The biotechnology industry achieved aggregate profitability in 2010 and funding improved, but levels of innovation capital still lag.

Outsourcing
The EU Debt Crisis and CMOs
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
The EU debt crisis portends of possible negative repercussions for the dose CMO industry.

CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and public and private organizations. This month, we feature articles on the UN General Assembly’s meeting on noncommunicable diseases, the pharmaceutical industry’s action plan for noncommunicable diseases, and a roundup of CSR and sustainability news.

UN General Assembly Address Issue of Noncommunicable Diseases in the Developing World
Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
The United Nations calls for a multistakeholder plan by 2013 to curb the rise of noncommunicable diseases.

The Pharmaceutical Industry Prioritizes Its Action Plan for Tackling Noncommunicable Diseases
Patricia Van Arnum, senior editor of Pharmaceutical Technology, and editor of Sourcing and Management
The International Federation of Pharmaceutical Manufacturers and Associations offers an action plan and research for addressing noncommunicable diseases.

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.